About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
Follow Us
Secure Payments
|
|
|
| Previous Close | $67.06 | Open | $67.84 |
| Volume | 1.62M | Market Cap | |
| Yield | Last Dividend | $0.19 |
| EYE DROPS AND LUBRICANTS MARKET 2020 IND... | 03/03/21 |
| The Global Eye Drops and Lubricants Market research report offers an in-depth analysis of the global market, providing relevant information for the ne... | |
| Cyclosporine Market 2021 - 2028 Growth A... | 03/03/21 |
| Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ???Cyclosporine Market: Global Opportunity Analysis and Industry Foreca... | |
| Ophthalmic Drugs Market Size to Reach Va... | 03/02/21 |
| The development of effective ophthalmic is crucial is the current scenario, owing to increase in incidence of ophthalmic disorders such as glaucoma, c... | |
| Alcon Reports Fourth Quarter and Full Ye... | 02/23/21 |
| GENEVA--(BUSINESS WIRE)--Alcon Reports Fourth Quarter and Full Year 2020 Results | |
| Alcon Factors Likely to Have Influenced ... | 02/22/21 |
| Alcon announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| Surgical Microscopes Market Regional Mar... | 11/24/20 |
| The global surgical microscopes market accounted for $447 million in 2020 and is estimated to reach $818 million by 2027, registering a CAGR of 8.9% d... | |
| Surgical Equipment Market With Top Leadi... | 11/19/20 |
| An off-the-shelf report on Surgical Equipment Market which has been compiled after an in-depth analysis of the market trends prevailing across five ge... | |
| Eye Health Supplements Market: Latest In... | 11/11/20 |
| According to our latest study on "Eye Health Supplements Market Forecast to 2027 - COVID-19 Impact and Analysis by Ingredient Type, Indication, and Fo... | |
| 16 Stocks Moving In Tuesday's After-Hour... | 11/10/20 |
| Gainers Lyft (NASDAQ: LYFT) shares are trading higher after the company reported better-than-expected Q3 sales results. Fair Isaac (NYSE: FICO) shares... | |
| Alcon Reports Third Quarter 2020 Results | 11/10/20 |
| GENEVA--(BUSINESS WIRE)--Alcon Reports Third Quarter 2020 Results | |
| The Daily Biotech Pulse: Lilly's COVID-1... | 11/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 9) Alco... | |
| Eye Health Supplements Market Strategic ... | 11/09/20 |
| The eye health supplements market was valued at US$ 1,572.33 million in 2019 and is projected to reach US$ 2,382.96 million by 2027; it is expected to... | |
| Wolfe Eye Clinic continues to advance vi... | 11/06/20 |
| DES MOINES, Iowa, Nov. 6, 2020 /PRNewswire/ -- Wolfe Eye Clinic cataract surgeon, James Davison, M.D., recently placed Iowa's first AcrySof?? IQ Vivit... | |
| Alcon U.S. PRECISION1 Launch Momentum Bo... | 11/05/20 |
| FORT WORTH, Texas--(BUSINESS WIRE)--Alcon U.S. PRECISION1 Launch Momentum Bolstered by Strong Programs, Differentiated On-Eye Performance | |
| Wavefront Aberrometer Market to explore ... | 10/08/20 |
| Wavefront aberrometry is an objective method of measuring refractive power, using a tool to measure the manner in which a light beam moves. Aberromete... | |
| Alcon Celebrates World Sight Day 2020 an... | 10/08/20 |
| GENEVA--(BUSINESS WIRE)--Alcon Celebrates World Sight Day 2020 and Continues Commitment to Improving Worldwide Access to Eye Care | |
| Ophthalmic Photocoagulator Market Influe... | 10/06/20 |
| The Ophthalmic Photocoagulator Market Report by Reports and Data provides an extensive overview of the vital elements of the Ophthalmic Photocoagulato... | |
| Dry Eye Syndrome Treatment Market 2020-2... | 10/01/20 |
| DBMR has added a new report titled Dry Eye Syndrome Treatment Market with analysis provides the insights which bring marketplace clearly into the focu... | |
| Ophthalmic Devices Market Checkout the U... | 10/01/20 |
| Global Ophthalmic Devices Market has been brewing up and influencing the international economy with respect to revenue, growth rate, sale, market shar... | |
| Glaucoma Surgery Devices Market With Top... | 10/01/20 |
| Glaucoma is a small device that is surgically inserted into the eye to increase the outflow of intraocular fluid and lessen high eye pressure. Surgery... | |
| Dry Eye Products Market In-Depth Analysi... | 09/30/20 |
| Los Angeles, United State, ??? ??? QY Research recently added a research report, Global Dry Eye Products Market Research Report 2020 to its ever-incre... | |
| Ophthalmic Lasers Market Checkout the Un... | 09/29/20 |
| Global Ophthalmic Lasers Market has been brewing up and influencing the international economy with respect to revenue, growth rate, sale, market share... | |
| Ophthalmology Microscopes Market Growth ... | 09/28/20 |
| BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as ???Global Ophthalmology Microscopes M... | |
| Global Wave-front Aberrometer Market: Gr... | 08/25/20 |
| DUBLIN--(BUSINESS WIRE)--The "Global Wave-front Aberrometer Market: Growth, Trends and Forecast (2020-2025)" report has been added to ResearchAndMarke... | |
| Ophthalmic Lens Market Analysis Highligh... | 08/06/20 |
| Technavio has been monitoring the ophthalmic lens market and it is poised to grow by USD 3.21 billion during 2020-2024, progressing at a CAGR of over ... | |
| COVID-19 Impacts: Allergy Rhinitis Drugs... | 07/29/20 |
| Technavio has been monitoring the allergy rhinitis drugs market and it is poised to grow by USD 2.4 bn during 2020-2024, progressing at a CAGR of almo... | |
| Strong Buy rating | 02/25/21 |
| Credit Suisse maintains Outperform rating and raises Price Target from $76.00 to $86.00 | |
| Strong Buy rating | 02/25/21 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $75.00 to $79.00 | |
| Strong Buy rating | 12/15/20 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $73.00 to $75.00 | |
| Date | 2021-02-23 (AMC) | Est. (EPS/Rev.) | $0.41/ 1.89B |
| Actual (EPS/Rev.) | $0.41/ $1.93 B | EPS (TTM) | -1.24 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.